Drug Shortage Report for GD-DICLOFENAC/MISOPROSTOL 50

Last updated on 2020-03-04 History
Report ID 99534
Drug Identification Number 02341689
Brand name GD-DICLOFENAC/MISOPROSTOL 50
Common or Proper name GD-DICLOFENAC/MISOPROSTOL 50
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) MISOPROSTOL DICLOFENAC SODIUM
Strength(s) 200MCG 50MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 250's
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-22
Estimated end date 2020-03-04
Actual end date 2020-03-03
Shortage status Resolved
Updated date 2020-03-04
Company comments Limited inventory available and on preventative allocation until approx March 4, 2020. Other presentation available: Arthrotec 50mg
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2020-03-04 French Compare
v12 2020-03-04 English Compare
v11 2020-02-12 French Compare
v10 2020-02-12 English Compare
v9 2020-01-10 French Compare
v8 2020-01-10 English Compare
v7 2019-12-17 French Compare
v6 2019-12-17 English Compare
v5 2019-12-04 French Compare
v4 2019-12-04 English Compare
v3 2019-11-23 English Compare
v2 2019-11-22 French Compare
v1 2019-11-22 English Compare

Showing 1 to 13 of 13